Operating Lease, Right-of-Use Asset of Verrica Pharmaceuticals Inc. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Verrica Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • Verrica Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $540,000, a 35% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Verrica Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $540,000 -$296,000 -35% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 $616,000 -$296,000 -32% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $690,000 -$315,000 -31% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $764,000 -$318,000 -29% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $836,000 -$322,000 -28% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 $912,000 -$427,000 -32% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $1,005,000 -$295,000 -23% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,082,000 -$290,000 -21% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,158,000 -$285,000 -20% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $1,339,000 -$174,000 -12% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,300,000 -$282,000 -18% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,372,000 -$176,000 -11% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,443,000 -$165,000 -10% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $1,513,000 -$153,000 -9.2% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,582,000 -$141,000 -8.2% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,548,000 -$232,000 -13% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,608,000 -$228,000 -12% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $1,666,000 -$225,000 -12% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $1,723,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $1,780,000 +$1,735,000 +3856% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $1,836,000 +$1,725,000 +1554% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q3 2020 $1,891,000 +$1,713,000 +962% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q1 2020 $45,000 -$230,000 -84% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $111,000 -$193,000 -63% 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q3 2019 $178,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $245,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $275,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $304,000 01 Jan 2019 10-K 17 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.